We are live on ! Find out more
PASG icon

Passage Bio
PASG

101 hedge funds and large institutions have $419M invested in Passage Bio in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

0.24% less ownership

Funds ownership: 4.13% → 3.89% (-0.24%)

1% less funds holding

Funds holding: 102 → 101 (-1)

6% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 17

6% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 31

25% less capital invested

Capital invested by funds: $557M → $419M (-$138M)

56% less call options, than puts

Call options by funds: $131K | Put options by funds: $300K

Holders
101
Holders Change
-1
Holders Change %
-0.98%
% of All Funds
1.77%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
16
Increased
29
Reduced
31
Closed
17
Calls
$131K
Puts
$300K
Net Calls
-$169K
Net Calls Change
+$74K

Top Buyers

1
WP
Woodline Partners
California
+$3.84M
2
HCM
Highline Capital Management
New York
+$2.25M
3
Millennium Management
Millennium Management
New York
+$1.78M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.51M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.42M

Top Sellers

1
State Street
State Street
Massachusetts
-$13.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.1M
3
EA
Emerald Advisers
Pennsylvania
-$4.24M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$3.84M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$69.3M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$56.1M -$11.1M -46,537 -14%
FM
3
Frazier Management
Washington
$49.9M – – –
VVM
4
Versant Venture Management
California
$49.4M – – –
BlackRock
5
BlackRock
New York
$31.1M +$200K +838 +0.5%
NLVP
6
New Leaf Venture Partners
New York
$24.9M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$19.8M +$1.42M +5,945 +6%
BC
8
Boxer Capital
California
$19.2M – – –
HCM
9
Highline Capital Management
New York
$11.8M +$2.25M +9,418 +19%
Morgan Stanley
10
Morgan Stanley
New York
$11.4M -$34.6K -145 -0.3%
JP Morgan Chase
11
JP Morgan Chase
New York
$7.82M +$170K +712 +2%
State Street
12
State Street
Massachusetts
$6.8M -$13.7M -57,401 -63%
VC
13
Vivo Capital
California
$5.37M -$1.27M -5,337 -17%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$4.71M -$665K -2,789 -11%
Wellington Management Group
15
Wellington Management Group
Massachusetts
$4.2M +$412K +1,730 +9%
Millennium Management
16
Millennium Management
New York
$3.43M +$1.78M +7,449 +76%
WMSA
17
Weiss Multi-Strategy Advisers
New York
$3.35M -$43.6K -183 -1%
Northern Trust
18
Northern Trust
Illinois
$3.27M -$168K -706 -4%
WP
19
Woodline Partners
California
$3.21M +$3.84M +16,090 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$3.12M +$221K +926 +6%
Charles Schwab
21
Charles Schwab
California
$2.5M +$640K +2,685 +27%
N
22
Nuveen
North Carolina
$2.17M -$95.9K -402 -4%
Two Sigma Investments
23
Two Sigma Investments
New York
$2.05M +$1.39M +5,817 +130%
Norges Bank
24
Norges Bank
Norway
$1.84M +$874K +3,666 +66%
Two Sigma Advisers
25
Two Sigma Advisers
New York
$1.58M +$1.51M +6,340 +400%
1
2 3 4 5

PASG Hedge Fund Activity: Q3 2021 in Review

101 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q3 2021, worth a combined $419M — down 25% from $557M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of PASG and 16 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 29 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $3.84M. The largest seller was State Street, cutting an estimated $13.7M.

  • 101 institutional investors held Passage Bio (PASG) as of Q3 2021, down from 102 in Q2 2021.
  • Funds reported $419M of Passage Bio stock for Q3 2021, down 25% quarter-over-quarter.
  • 16 funds opened new Passage Bio positions in Q3 2021 and 17 closed out, a net change of -1 holder.
  • The largest Passage Bio buyer in Q3 2021 was Woodline Partners, an estimated $3.84M added.
  • The largest Passage Bio seller in Q3 2021 was State Street, an estimated $13.7M sold.

Based on aggregated 13F filings for Q3 2021.